In February of 2026, Congress enacted several PBM-related provisions in H.R.7148, the Consolidated Appropriations Act, 2026
Ethics declarations Conflict of interest The authors declare that they have no competing interests to disclose
GHK-Cu GHK-Cu is a copper-associated peptide commonly discussed in copper-peptide, matrix, structural-signaling, aesthetics, and longevity research contexts
This medicine really changed my thinking." Over the past several years, medications that can lead to weight loss, from Wegovy to Zepbound, Ozempic and Mounjaro, have changed the landscape of obesity medicine, from how weight loss is treated medically to how the public perceives thought about obesity
Weight loss doesnt end when you reach a number
Your body makes GHK-Cu on its own